Safety and efficacy of encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer: A systematic review and single-arm meta-analysis

被引：0
|
作者：
Celso, D. S. G. [1 ]
Defante, M. L. R. [2 ]
Alzogaray, V. [3 ]
Torres, L. A. [4 ]
Lopes, A. C. Melo [5 ]
Bearse, M. [6 ]
机构：
[1] UFV Univ Fed Vicosa, DEM, Vicosa, MG, Brazil
[2] UniRedentor Afya, Med, Itaperuna, Brazil
[3] Fac Chem, Montevideo, Uruguay
[4] UFRN Univ Fed Rio Grande Norte, ULAP, Natal, RN, Brazil
[5] Houston Methodist Res Inst, Pathol & Genom Med, Houston, TX USA
[6] Yale New Haven Hosp Primary Care Ctr, Pathol, New Haven, CT USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.072
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
61P
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Lieberman, Jeffrey A.
    Dosovitz, Simon M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 879 - 879
  • [2] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Roviello, Giandomenico
    D'Angelo, Alberto
    Petrioli, Roberto
    Roviello, Franco
    Cianchi, Fabio
    Nobili, Stefania
    Mini, Enrico
    Lavacchi, Daniele
    [J]. TRANSLATIONAL ONCOLOGY, 2020, 13 (09):
  • [3] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
    Kopetz, S.
    Grothey, A.
    Yaeger, R.
    Van Cutsem, E.
    Desai, J.
    Yoshino, T.
    Wasan, H.
    Ciardiello, F.
    Loupakis, F.
    Hong, Y. S.
    Steeghs, N.
    Guren, T. K.
    Arkenau, H. -T.
    Garcia-Alfonso, P.
    Pfeiffer, P.
    Orlov, S.
    Lonardi, S.
    Elez, E.
    Kim, T. -W.
    Schellens, J. H. M.
    Guo, C.
    Krishnan, A.
    Dekervel, J.
    Morris, V.
    Calvo Ferrandiz, A.
    Tarpgaard, L. S.
    Braun, M.
    Gollerkeri, A.
    Keir, C.
    Maharry, K.
    Pickard, M.
    Christy-Bittel, J.
    Anderson, L.
    Sandor, V.
    Tabernero, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1632 - 1643
  • [4] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer Reply
    Gardner, Caleb
    Kleinman, Arthur
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 880 - 880
  • [5] Acute renal failure under encorafenib, binimetinib and cetuximab for BRAF V600E-mutated colorectal cancer
    Stammler, Romain
    Gallois, Claire
    Taieb, Julien
    Duong, Jean-Paul
    Karras, Alexandre
    Thervet, Eric
    Lazareth, Helene
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 147 : 60 - 62
  • [6] Cost-Effectiveness Analysis of Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Metastatic Colorectal Cancer in the USA
    Li, Shuosha
    Hu, Huabin
    Ding, Dong
    Zhu, Youwen
    Huang, Jin
    [J]. ADVANCES IN THERAPY, 2021, 38 (03) : 1650 - 1659
  • [7] Cost-Effectiveness Analysis of Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Metastatic Colorectal Cancer in the USA
    Shuosha Li
    Huabin Hu
    Dong Ding
    Youwen Zhu
    Jin Huang
    [J]. Advances in Therapy, 2021, 38 : 1650 - 1659
  • [8] Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer: an early post-marketing phase vigilance study
    Sakata, Hidenori
    Murase, Maki
    Kato, Takeshi
    Yamaguchi, Kensei
    Sugihara, Kenichi
    Suzuki, Shigenobu
    Yoshino, Takayuki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (01) : 139 - 144
  • [9] Cost-effectiveness of encorafenib plus cetuximab in BRAF V600E-mutated colorectal cancer
    Giuliani, Jacopo
    Mantoan, Beatrice
    Bonetti, Andrea
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (01) : 199 - 202
  • [10] Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
    Gallois, C.
    Bergen, E. S.
    Auclin, E.
    Pernot, S.
    Higue, J.
    Trouilloud, I.
    Touchefeu, Y.
    Turpin, A.
    Mazard, T.
    Sartore-Bianchi, A.
    Prenen, H.
    Alberti, A.
    Pilla, L.
    Cuissy, S.
    Wookey, V.
    Perret, A.
    Melchior, C.
    Artru, P.
    Dubreuil, O.
    Drouillard, A.
    Doat, S.
    Lavole, J.
    Basile, D.
    Perkins, G.
    Jary, M.
    Stintzing, S.
    Jos, J.
    Tougeron, D.
    Taieb, J.
    [J]. ESMO OPEN, 2024, 9 (09)
12345